2011 Analytical Chemistry DNA Drug Development 
Drug Discovery World
MARCH 7, 2023
Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Prior to Twist Bioscience, she worked at Agilent Technologies and at the University of Houston developing DNA and RNA parallel synthesis processes on solid support.
Drug Discovery World
OCTOBER 14, 2022
HTS as a tool for drug discovery has evolved rapidly since the origin of the technique in the 1990s. Using timsTOF technology as an HTS read-out method has the potential to significantly enhance the efficiency of the drug development process by increasing lead quality and providing access to a new drug target space in early drug discovery.
Expert insights. Personalized for you.
246 
Let's personalize your content